Penn Medicine Provider
Gynecologic Oncology
Bethany Bustamante, MD
5.0
(193)
Accepting new patients
Sees patients age 18 and up
LG Health Physicians Gynecologic Oncology

About me

  • Adjunct Assistant Professor of Obstetrics and Gynecology

Education and training

  • Medical School: Marshall University School of Medicine
  • Residency: White Memorial Medical Center
  • Fellowship: NorthwellHealth

What my patients think about me

Average Rating
5.0

195 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
very kind, understanding, and knowledgeable of what she does!
May 2025
5.0
5.0
dr bustamante is so empathetic, attentive to test results, exams and is very thorough with her assessments. kind and caring!
April 2025
5.0
5.0
very knowledgeable
April 2025
5.0
5.0
spent a bunch of time with me and took my pain seriously

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Lancaster General Hospital: Has privileges to treat patients in the hospital.
Dr. Bustamante is a Penn Medicine Lancaster General Health physician.

Qualifications and experience

Treatments and Conditions

My research

Bustamante B, Sinha R, Rice B, Shan W, Goldberg GL, John V, Lin DI, Danziger N, Pavlick DC, Elvin JA, Frimer M Clinical implications of genomic loss of heterozygosity in endometrial carcinoma. , JCO Precis Oncol, 5:PO.20.00393: 2021


Bustamante B, DeVoti J, Papayannakos C, Mohd I, Lam F, Steinberg B, Bonagura V, Goldbergy GL Circulating immune cells of patients with cervical dysplasia and cancer do not show elevated baseline expression of COX2. Poster presentation, , American Association for Cancer Research, Annual Meeting: 2021


Sinha R, Bustamante B, Truskinovsky A, Shih K Yolk sac tumor of the endometrium in a post-menopausal woman: Case report and review of the literature. , Gynecol Oncol Rep, 36:10074: 2021


Bustamante B, Sinha R, John V, Goldberg GL, Frimer M Does Genomic Loss of Heterozygosity (gLOH) in Endometrial Carcinomas (EC) predict platinum sensitivity (PS)? Poster presentation, , Society of Gynecology Oncology, Annual Meeting on Women’s Cancer: 2021


Scanlon L, Nizam A, Bustamante B, Shih, KK, Shan W, dos Santos L, Frimer M, Menzin AW, Sakaris A, Whyte JS, Goldberg GL Utilization of vaginal brachytherapy in locally advanced cervical cancer. Poster presentation, , SGO 2020 Annual Meeting on Women’s Cancer: 2021


Sinha R, Bustamante B, Tahmasebi F, Goldberg GL Malignant Female Adnexal Tumor of Probable Wolffian Origin (FATWO): A case report and review for the literature. , Gynecol Oncol Rep, 36:100726: 2021


Seay K, Akanbi T, Bustamante B, Chaudhary S, Goldberg GL Mesonephric-like adenocarcinoma of the ovary with co-existent endometriosis: A case report and review of the literature. , Gynecol Oncol Rep, 34:100657: 2020


Seay K, Bustamante B, Khutti S, Frimer M A case of non-HPV related primary endometrioid adenocarcinoma of the cervix. , Gynecol Oncol Rep, 32:10057: 2020


Nizam A, Bustamante B, Shih, KK, Shan W, dos Santos L, Frimer M, Menzin AW, Sakaris A, Whyte JS, Goldberg GL Neoadjuvant chemotherapy for stage III ovarian cancer: a single-institution experience. Poster presentation, , SGO 2020 Annual Meeting on Women’s Cancer: 2020


Nelson D, Nizam A, Bustamante B, Shih KK, Shan W, dos Santos L, Frimer M, Menzin AW, Sakaris A, Whyte JW, Goldberg GL What is the clinical significance of grade 2 histology in women with stage IA endometrial cancer? Poster presentation, , SGO 2020 Annual Meeting on Women’s Cancer: 2020